Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJ4MF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,771
Award facts
- Contract value 100% obligated
- $19,771.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,771.26 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Stelara is a biologic immunosuppressant medication used to treat autoimmune conditions, and this order represents a routine pharmaceutical procurement to support federal military and healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of delivery orders with the Defense Logistics Agency's Medical Supply Chain, fulfilling essential pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJ4MF?
SPE2DB25FJ4MF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FJ4MF worth?
The government has obligated $19,771 on SPE2DB25FJ4MF.
Is contract SPE2DB25FJ4MF an order under another contract?
Yes. SPE2DB25FJ4MF is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4MF competed?
The extent of competition for SPE2DB25FJ4MF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award